Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6185) 6185
Book Chapter (138) 138
Dissertation (10) 10
Magazine Article (7) 7
Conference Proceeding (6) 6
Web Resource (6) 6
Newsletter (3) 3
Publication (2) 2
Book / eBook (1) 1
Journal / eJournal (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4911) 4911
science & technology (3275) 3275
life sciences & biomedicine (3179) 3179
male (2816) 2816
female (2724) 2724
rhabdomyosarcoma (2552) 2552
child (2334) 2334
child, preschool (1754) 1754
oncology (1691) 1691
adolescent (1667) 1667
rhabdomyosarcoma - pathology (1578) 1578
biological and medical sciences (1357) 1357
rhabdomyosarcoma - therapy (1351) 1351
medical sciences (1334) 1334
rhabdomyosarcoma - drug therapy (1250) 1250
infant (1235) 1235
adult (1155) 1155
tumors (1044) 1044
pediatrics (996) 996
combined modality therapy (954) 954
animals (892) 892
rhabdomyosarcoma - radiotherapy (838) 838
chemotherapy (775) 775
prognosis (758) 758
abridged index medicus (727) 727
antineoplastic combined chemotherapy protocols - therapeutic use (714) 714
rhabdomyosarcoma - surgery (695) 695
rhabdomyosarcoma - diagnosis (663) 663
cancer (649) 649
surgery (602) 602
middle aged (569) 569
sarcoma (551) 551
treatment outcome (506) 506
mice (456) 456
rhabdomyosarcoma - mortality (448) 448
retrospective studies (431) 431
radiotherapy (411) 411
pathology (408) 408
aged (394) 394
children (394) 394
follow-up studies (386) 386
neoplasm staging (383) 383
cell line, tumor (376) 376
hematology (370) 370
diagnosis, differential (359) 359
metastasis (331) 331
immunohistochemistry (330) 330
diseases of the osteoarticular system (329) 329
rhabdomyosarcoma - genetics (329) 329
care and treatment (326) 326
tumors of striated muscle and skeleton (324) 324
rats (319) 319
rhabdomyosarcoma - metabolism (312) 312
pharmacology. drug treatments (311) 311
neoplasm metastasis (305) 305
survival rate (299) 299
radiology, nuclear medicine & medical imaging (293) 293
time factors (290) 290
radiotherapy dosage (287) 287
rhabdomyosarcoma, embryonal - pathology (284) 284
antineoplastic agents (280) 280
diagnosis (277) 277
tomography, x-ray computed (273) 273
health aspects (270) 270
antineoplastic agents - therapeutic use (269) 269
infant, newborn (260) 260
magnetic resonance imaging (257) 257
young adult (252) 252
patients (251) 251
radiation therapy (250) 250
research (250) 250
vincristine - administration & dosage (234) 234
medicine & public health (230) 230
disease-free survival (226) 226
analysis (224) 224
biopsy (222) 222
cell biology (215) 215
rhabdomyosarcoma - diagnostic imaging (211) 211
rhabdomyosarcoma, alveolar - pathology (211) 211
gene expression (208) 208
cyclophosphamide - administration & dosage (200) 200
neoplasm recurrence, local (198) 198
soft tissue neoplasms - pathology (198) 198
medical prognosis (196) 196
sarcoma - pathology (195) 195
apoptosis (193) 193
fatal outcome (193) 193
neoplasm transplantation (193) 193
rhabdomyosarcoma - secondary (193) 193
dactinomycin - administration & dosage (189) 189
medicine (183) 183
risk factors (178) 178
dactinomycin - therapeutic use (177) 177
vincristine - therapeutic use (175) 175
sarcoma - therapy (173) 173
age factors (172) 172
survival analysis (166) 166
sarcoma - drug therapy (165) 165
rhabdomyosarcoma, embryonal - therapy (164) 164
chemotherapy, adjuvant (162) 162
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5782) 5782
French (174) 174
German (150) 150
Japanese (110) 110
Spanish (61) 61
Polish (57) 57
Russian (50) 50
Chinese (45) 45
Italian (26) 26
Portuguese (14) 14
Dutch (6) 6
Croatian (5) 5
Danish (3) 3
Korean (3) 3
Romanian (3) 3
Serbian (3) 3
Swedish (3) 3
Bulgarian (2) 2
Hebrew (2) 2
Hungarian (2) 2
Turkish (2) 2
Afrikaans (1) 1
Czech (1) 1
Finnish (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma
by Buszek, Samantha M and Ludmir, Ethan B and Grosshans, David R and McAleer, Mary F and McGovern, Susan L and Harrison, Douglas J and Okcu, M. Fatih and Chintagumpala, Murali M and Mahajan, Anita and Paulino, Arnold C
Pediatric blood & cancer, ISSN 1545-5009, 11/2019, Volume 66, Issue 11, pp. e27952 - n/a
prostate | rhabdomyosarcoma | proton beam radiotherapy | bladder | pediatric | Pediatrics | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Prostatic Neoplasms - radiotherapy | Prospective Studies | Follow-Up Studies | Humans | Proton Therapy - adverse effects | Child, Preschool | Infant | Male | Risk | Rhabdomyosarcoma, Embryonal - surgery | Urinary Bladder Neoplasms - pathology | Female | Registries | Rhabdomyosarcoma, Alveolar - pathology | Prostatic Neoplasms - drug therapy | Rhabdomyosarcoma, Embryonal - pathology | Rhabdomyosarcoma, Alveolar - drug therapy | Prostatic Neoplasms - pathology | Rhabdomyosarcoma, Alveolar - surgery | Prostatic Neoplasms - surgery | Kaplan-Meier Estimate | Proportional Hazards Models | Rhabdomyosarcoma, Alveolar - radiotherapy | Combined Modality Therapy | Rhabdomyosarcoma, Embryonal - drug therapy | Tumor Burden | Urinary Bladder Neoplasms - drug therapy | Urinary Bladder Neoplasms - surgery | Urinary Incontinence - etiology | Radiation Injuries - etiology | Cystectomy | Proctitis - etiology | Urinary Bladder Neoplasms - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Progression-Free Survival | Prostatectomy | Proton Therapy - methods | Neoplasm Staging | Rhabdomyosarcoma, Embryonal - radiotherapy | Failure rates | Polybutylene terephthalates | Toxicity | Medical treatment | Rhabdomyosarcoma | Health risks | Clinical trials | Bladder | Histology | Radiation therapy | Disease control | Survival | Patients | Urinary incontinence | Chemotherapy | Proctitis | Toxic diseases | Prostate | Tumors | Predictive control | Proton beams | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Role of radiation therapy in the conservative management of sarcoma within an irradiated field
by Modesto, A and Filleron, T and Chevreau, C and Le Pechoux, C and Rochaix, P and Le Guellec, S and Ducassou, A and Gangloff, D and Ferron, G and Delannes, M
European journal of surgical oncology, ISSN 0748-7983, 2013, Volume 40, Issue 2, pp. 187 - 192
Hematology, Oncology and Palliative Medicine | Surgery | Reirradiation | Radio-induced sarcoma | Radiation therapy | Sarcoma | Functional outcome | Oncology | Life Sciences & Biomedicine | Science & Technology | Breast Neoplasms - surgery | Neoplasms, Radiation-Induced - surgery | Humans | Middle Aged | Child, Preschool | Male | Leiomyosarcoma - radiotherapy | Pelvic Neoplasms - radiotherapy | Young Adult | Rhabdomyosarcoma - radiotherapy | Leiomyosarcoma - surgery | Pelvic Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Rhabdomyosarcoma - drug therapy | Retrospective Studies | Radiotherapy, Adjuvant | Child | Sarcoma - radiotherapy | Neoplasms, Radiation-Induced - radiotherapy | Pelvic Neoplasms - surgery | Hemangiosarcoma - drug therapy | Head and Neck Neoplasms - drug therapy | Treatment Outcome | Combined Modality Therapy | Sarcoma - drug therapy | Breast Neoplasms - drug therapy | Neoplasms, Radiation-Induced - drug therapy | Disease-Free Survival | Head and Neck Neoplasms - radiotherapy | Breast Neoplasms - radiotherapy | Hemangiosarcoma - surgery | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Sarcoma - surgery | Adolescent | Hemangiosarcoma - radiotherapy | Leiomyosarcoma - drug therapy | Aged | Rhabdomyosarcoma - surgery | Head and Neck Neoplasms - surgery | Cohort Studies | Radiotherapy | Nuclear radiation | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Socioeconomic factors affect the selection of proton radiation therapy for children
by Shen, Colette J and Hu, Chen and Ladra, Matthew M and Narang, Amol K and Pollack, Craig E and Terezakis, Stephanie A
Cancer, ISSN 0008-543X, 10/2017, Volume 123, Issue 20, pp. 4048 - 4056
radiotherapy | socioeconomic factors | protons | photons | malignancy | pediatrics | Life Sciences & Biomedicine | Oncology | Science & Technology | Radiotherapy - utilization | United States | Humans | Brain Neoplasms - pathology | Child, Preschool | Rhabdomyosarcoma - pathology | Infant | Male | Educational Status | Bone Neoplasms - pathology | Socioeconomic Factors | Insurance, Health - statistics & numerical data | Young Adult | Neoplasm Metastasis | Rhabdomyosarcoma - radiotherapy | Medulloblastoma - radiotherapy | Medulloblastoma - pathology | Ependymoma - pathology | Female | Neoplasms - radiotherapy | Cerebellar Neoplasms - pathology | Brain Neoplasms - radiotherapy | Medicaid | Odds Ratio | Child | Infant, Newborn | Proton Therapy - utilization | Income - statistics & numerical data | Medically Uninsured | Logistic Models | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Managed Care Programs | Travel | Bone Neoplasms - radiotherapy | Adolescent | Neoplasms - pathology | Cerebellar Neoplasms - radiotherapy | Ependymoma - radiotherapy | Usage | Children | Radiotherapy | Social economics | Health aspects | Analysis | Health care | Pediatrics | Populations | Socio-economic aspects | Radiation | Rhabdomyosarcoma | Economic factors | Social factors | Malignancy | Radiation therapy | Regression analysis | Tissues | Cancer therapies | Patients | Socioeconomics | Metastases | Confidence intervals | Government programs | Socioeconomic factors | Medulloblastoma | Background radiation | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Prognostic factors of overall survival in children and adolescents enrolled in dose-finding trials in Europe: An Innovative Therapies for Children with Cancer study
by Carceller, Fernando and Bautista, Francisco J and Jiménez, Irene and Hladun-Álvaro, Raquel and Giraud, Cécile and Bergamaschi, Luca and Dandapani, Madhumita and Aerts, Isabelle and Doz, François and Frappaz, Didier and Casanova, Michela and Morland, Bruce and Hargrave, Darren R and Marshall, Lynley V and Vassal, Gilles and Pearson, Andrew D.J and Geoerger, Birgit and Moreno, Lucas
European journal of cancer (1990), ISSN 0959-8049, 2016, Volume 67, pp. 130 - 140
Hematology, Oncology and Palliative Medicine | Innovative Therapies for Children with Cancer | Dose-finding trial | Prognostic factor | Phase I trial | Children | Adolescents | Survival | Life Sciences & Biomedicine | Oncology | Science & Technology | Osteosarcoma - drug therapy | Multivariate Analysis | Prognosis | Neuroectodermal Tumors, Primitive - drug therapy | Humans | Child, Preschool | Infant | Male | Neuroblastoma - mortality | Sarcoma, Ewing - mortality | Medulloblastoma - mortality | Ependymoma - drug therapy | Employment | Ependymoma - mortality | Sarcoma - mortality | Female | Rhabdomyosarcoma - drug therapy | Retrospective Studies | Child | Rhabdomyosarcoma - mortality | Schools | Osteosarcoma - mortality | Glioma - mortality | Neuroectodermal Tumors, Primitive - mortality | Europe | Proportional Hazards Models | Neoplasms - mortality | Therapies, Investigational | Survival Rate | Sarcoma - drug therapy | Neoplasms - drug therapy | Sarcoma, Ewing - drug therapy | Neuroblastoma - drug therapy | Adolescent | Medulloblastoma - drug therapy | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Clinical Trials, Phase I as Topic | Glioma - drug therapy | Care and treatment | Patient outcomes | Children's hospitals | Oncology, Experimental | Clinical trials | Research | Health aspects | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies
by Knott, Maximilian M. L and Hoelting, Tilman L. B and Ohmura, Shunya and Kirchner, Thomas and Cidre-Aranaz, Florencia and Gruenewald, Thomas G. P
Cancer and metastasis reviews, ISSN 0167-7659, 01/2020, Volume 38, Issue 4, pp. 625 - 642
Life Sciences & Biomedicine | Oncology | Science & Technology | Rhabdomyosarcoma, Alveolar - drug therapy | Oncogene Proteins, Fusion - metabolism | Sarcoma, Ewing - metabolism | Bone Neoplasms - therapy | Sarcoma, Ewing - therapy | Humans | Sarcoma - drug therapy | Sarcoma - therapy | Bone Neoplasms - metabolism | Sarcoma - metabolism | Rhabdomyosarcoma, Alveolar - therapy | Animals | Rhabdomyosarcoma, Alveolar - metabolism | Oncogene Proteins, Fusion - genetics | Pediatrics - methods | CRISPR-Cas Systems | Bone Neoplasms - genetics | Bone Neoplasms - drug therapy | Sarcoma - genetics | Sarcoma, Ewing - genetics | Child | Genetic Therapy - methods | FOXO1 protein | Synovial sarcoma | Rhabdomyosarcoma | Children | Mutation | Pax3 protein | FLI-1 protein | Ewing's sarcoma | Tumors | Ewings sarcoma | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Targeted Therapy-based Combination Treatment in Rhabdomyosarcoma
by Erp, A.E.M. van and Versleijen-Jonkers, Y.M.H and Graaf, W.T.A. van der and Fleuren, E.D.G
Molecular cancer therapeutics, ISSN 1535-7163, 2018, Volume 17, Issue 7, pp. 1365 - 1380
Life Sciences & Biomedicine | Oncology | Science & Technology | Animals | Signal Transduction - drug effects | Humans | Rhabdomyosarcoma - etiology | Rhabdomyosarcoma - metabolism | Clinical Trials as Topic | Combined Modality Therapy | Gene Expression Regulation, Neoplastic - drug effects | Drug Evaluation, Preclinical | Molecular Targeted Therapy | Biomarkers, Tumor | Rhabdomyosarcoma - therapy | Tyrosine | Regulators | Sarcoma | Medical treatment | DNA damage | Rhabdomyosarcoma | Cell fusion | Kinases | Insulin | Cancer therapies | Proteins | Signal transduction | Signaling | Chemotherapy | Hedgehog protein | Alveoli | Deoxyribonucleic acid--DNA | Cancer | Apoptosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish
by Yan, Chuan and Brunson, Dalton C and Tang, Qin and Do, Daniel and Iftimia, Nicolae A and Moore, John C and Hayes, Madeline N and Welker, Alessandra M and Garcia, Elaine G and Dubash, Taronish D and Hong, Xin and Drapkin, Benjamin J and Myers, David T and Phat, Sarah and Volorio, Angela and Marvin, Dieuwke L and Ligorio, Matteo and Dershowitz, Lyle and McCarthy, Karin M and Karabacak, Murat N and Fletcher, Jonathan A and Sgroi, Dennis C and Iafrate, John A and Maheswaran, Shyamala and Dyson, Nick J and Haber, Daniel A and Rawls, John F and Langenau, David M
Cell (Cambridge), ISSN 0092-8674, 06/2019, Volume 177, Issue 7, pp. 1903 - 1914.e14
xenograft | prkdc | melanoma | breast cancer | immune deficient | zebrafish | rhabdomyosarcoma | il2rg | SCID | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Neoplasm Transplantation | Zebrafish - immunology | Humans | Muscle Neoplasms - pathology | Rhabdomyosarcoma - metabolism | Rhabdomyosarcoma - pathology | Male | Muscle Neoplasms - immunology | Temozolomide - pharmacology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Heterografts | Female | Rhabdomyosarcoma - drug therapy | Muscle Neoplasms - drug therapy | Rhabdomyosarcoma - immunology | Animals, Genetically Modified - metabolism | Piperazines - pharmacology | Zebrafish - genetics | Xenograft Model Antitumor Assays | Phthalazines - pharmacology | Animals, Genetically Modified - immunology | Animals | Animals, Genetically Modified - genetics | Zebrafish - metabolism | K562 Cells | Muscle Neoplasms - metabolism | Antimitotic agents | Medical research | Medical colleges | Care and treatment | Microbiology | Analysis | Melanoma | Stem cells | Medicine, Experimental | Antineoplastic agents | Health aspects | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Suicide gene therapy of rhabdomyosarcoma
by Konieczny, Paweł and Sułkowski, Maciej and Badyra, Bogna and Kijowski, Jacek and Majka, Marcin
International journal of oncology, ISSN 1019-6439, 02/2017, Volume 50, Issue 2, pp. 597 - 605
Suicide gene therapy | Thymidyne kinase | Ganciclovir | Bystander effect | Rhabdomyosarcoma | HSV-TK | Life Sciences & Biomedicine | Oncology | Science & Technology | Cell Survival - drug effects | Genes, Transgenic, Suicide | Genetic Vectors - administration & dosage | Thymidine Kinase - genetics | Humans | Simplexvirus - genetics | Gene Expression Regulation, Neoplastic | Simplexvirus - enzymology | Xenograft Model Antitumor Assays | Animals | Bystander Effect - drug effects | Cell Line, Tumor | Ganciclovir - pharmacology | Cell Proliferation - drug effects | Mice | Rhabdomyosarcoma - genetics | Rhabdomyosarcoma - therapy | Ganciclovir - administration & dosage | Genetic Therapy - methods
Journal Article
Details down arrow